glp 1 and glp 2 drugs Is GLP-1 the Same as Ozempic? Understanding Key Differences GLP-1 Drug Comparison in Diabetes

Several studies have served up tantalizing hints about the drugs potential benefits, but other results land all over the map

So even though there were steps that employees had to take, it was usually denied the first time and they had to go through an appeal process

Sherrill CH, Hwang AY

On June 10th, researchers from Eli Lilly published findings of a randomized phase 2a clinical trial in "Nature Medicine" titled Triple hormone receptor agonist retatrutide for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a trial. The study indicated that Retatrutide (LY3437943), a GLP-1R-related triple receptor agonist currently under clinical development, demonstrated significant efficacy and favorable safety in the treatment of metabolic dysfunction-associated steatotic liver disease (MASLD)

(EASD) AMERICAN SOCIETY OF ENDOCRINE PHYSICIAN ASSISTANTS American Diabetes Association Canadian Cardiovascular Society European Association for the Study of Obesity (EASO) #eSPACEHF2025 #HeartFailure #GDMT #MeetTheExpert #CardiologyEducation #HeartFailureCare #HFManagement To view or add a comment, sign in Could early kidney function decline be a hidden sign of worsening congestion in heart failure

Medical Safety and Oversight Every GLP-1 therapy requires a professional medical evaluation